A previous Merck researcher is now assisting litigation against such drug manufacturers over diabetes treatments that he found were linked to pancreatic cancer.
Dr. Peter Butler tested Merck’s drug Januvia on rats in 2008 and discovered changes in the rats’ pancreases that he worried could lead to cancer. Butler’s follow-up research to confirm the linkage is now fueling investigations by the FDA and European Medicines Agency into drugs like Januvia.
Source: The New York Times